Ríhová B - Search Results

1

HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia.

St'astný M, Plocová D, Etrych T, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: rihova b. Eur J Cancer. 2002 Mar;38(4):602-8. doi: 10.1016/s0959-8049(01)00421-x. Eur J Cancer. 2002. PMID: 11872356

2

Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.

Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Kovár M, et al. Among authors: rihova b. Bioconjug Chem. 2002 Mar-Apr;13(2):206-15. doi: 10.1021/bc010063m. Bioconjug Chem. 2002. PMID: 11906257

3

HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.

St'astný M, Plocová D, Etrych T, Kovár M, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: rihova b. J Control Release. 2002 May 17;81(1-2):101-11. doi: 10.1016/s0168-3659(02)00047-0. J Control Release. 2002. PMID: 11992683

4

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.

Jelínková M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Jelínková M, et al. Among authors: rihova b. Pharm Res. 2003 Oct;20(10):1558-64. doi: 10.1023/a:1026170830782. Pharm Res. 2003. PMID: 14620507

5

A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier.

St'astný M, Strohalm J, Plocová D, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: rihova b. Eur J Cancer. 1999 Mar;35(3):459-66. doi: 10.1016/s0959-8049(98)00373-6. Eur J Cancer. 1999. PMID: 10448300

6

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.

Etrych T, Jelínková M, Ríhová B, Ulbrich K. Etrych T, et al. Among authors: rihova b. J Control Release. 2001 May 18;73(1):89-102. doi: 10.1016/s0168-3659(01)00281-4. J Control Release. 2001. PMID: 11337062

7

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.

Ríhová B, Etrych T, Pechar M, Jelínková M, Stastný M, Hovorka O, Kovár M, Ulbrich K. Ríhová B, et al. J Control Release. 2001 Jul 6;74(1-3):225-32. doi: 10.1016/s0168-3659(01)00320-0. J Control Release. 2001. PMID: 11489498

8

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs.

Ríhová B, Strohalm J, Kubácková K, Jelínková M, Hovorka O, Kovár M, Plocová D, Sírová M, St'astný M, Rozprimová L, Ulbrich K. Ríhová B, et al. J Control Release. 2002 Jan 17;78(1-3):97-114. doi: 10.1016/s0168-3659(01)00489-8. J Control Release. 2002. PMID: 11772452

9

Differences in the intracellular fate of free and polymer-bound doxorubicin.

Hovorka O, St'astný M, Etrych T, Subr V, Strohalm J, Ulbrich K, Ríhová B. Hovorka O, et al. Among authors: rihova b. J Control Release. 2002 Apr 23;80(1-3):101-17. doi: 10.1016/s0168-3659(02)00016-0. J Control Release. 2002. PMID: 11943391

10

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.

Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. Ulbrich K, et al. Among authors: rihova b. J Control Release. 2003 Feb 21;87(1-3):33-47. doi: 10.1016/s0168-3659(02)00348-6. J Control Release. 2003. PMID: 12618021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters